Global Safety Syringe Market Poised for Growth, Expected to Reach $12.6 Billion by 2028

June 25, 2024 02:06 PM BST | By EIN Presswire
 Global Safety Syringe Market Poised for Growth, Expected to Reach $12.6 Billion by 2028
Image source: EIN Presswire

LONDON, GREATER LONDON, UK, June 25, 2024 /EINPresswire.com/ -- The global safety syringe market size has shown robust growth in recent years. It is projected to grow from $8.19 billion in 2023 to $8.95 billion in 2024, at a compound annual growth rate (CAGR) of 9.2%. This growth can be attributed to concerns over needlestick injuries, regulatory mandates, increased adoption of safety measures, the rising prevalence of blood-borne diseases, and the expansion of healthcare infrastructure. By 2028, the market is expected to reach $12.6 billion, growing at a CAGR of 8.9%. The forecasted growth is driven by vaccination initiatives, a rising geriatric population, a heightened focus on preventive healthcare, an expanding biopharmaceutical industry, and advancements in material sciences.

Rising Blood-Borne Diseases Drive Market Growth
The increasing number of blood-borne diseases is a significant factor propelling the growth of the safety syringe market. Blood-borne diseases, caused by microorganisms like bacteria, viruses, or parasites, are transmitted through blood. Safety syringes play a crucial role in protecting healthcare workers and patients from these risks by reducing the likelihood of accidental exposures and promoting best practices in medical procedures. For instance, according to Contagion Live, a US-based news source, blood-borne infection rates increased by 14% in 2020–2021, with 5,023 confirmed cases of hepatitis C virus (HCV) and an estimated 69,800 infections. Furthermore, 43 states in the US reported 107,540 newly diagnosed cases of HCV in the same period. The rising number of blood-borne diseases is driving the growth of the safety syringe market.

Explore comprehensive insights into the global safety syringe market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=13924&type=smp

Key Players and Market Trends
Major companies operating in the safety syringe market include Cardinal Health Inc., Retractable Technologies Inc., Thermo Fisher Scientific Inc., Medtronic plc, Novo Nordisk A/S, Becton, Dickinson and Company, Baxter International Inc., Boston Scientific Corporation, Medline Industries LP, Terumo Corporation, B. Braun Melsungen AG, West Pharmaceutical Services Inc., Fresenius Kabi AG, Nemera, Smiths Medical International Ltd., Nipro Medical Corporation, Henke-Sass Wolf GmbH, Revolutions Medical Inc., Sol-Millennium Inc., UltiMed Inc., Unilife Corporation, AdvaCare Pharma, Axol Bio Corporation, Vita Needle Company, Numedico Technologies Pty Ltd., Duopross Meditech Corporation, DMC Medical Ltd., and Guangdong Haiou Medical Apparatus Co. Ltd.

Companies in the safety syringe market are focusing on developing new products, such as passive needle guards, to gain a competitive edge. For instance, in November 2021, Becton, Dickinson, and Company launched the BD UltraSafe Plus 2.25 mL Passive Needle Guard, an innovative addition to its drug delivery systems. This product is designed for the subcutaneous delivery of biologic solutions with volumes up to 2 mL and viscosities up to 30 cP, enhancing the self-injection experience for patients, caregivers, and healthcare providers. The BD UltraSafe Plus 2.25 mL is aligned with the BD Neopak 2.25 mL Glass Prefillable Syringe, supporting bio-pharmaceutical drug launches with convenience and ease of use.

Segments:
The safety syringe market covered in this report is segmented –
1) By Product: Retractable Safety Syringes, Non Retractable Safety Syringes
2) By Therapy: Insulin, Glucagon-like peptide-I (CLP-I), Tuberculosis, Growth Hormones
3) By Application: Subcutaneous, Intramuscular
4) By End-user: Hospitals, Ambulatory Surgical Centers, Long-term Care Facilities, Specialty Clinics, Other End Users

Geographical Insights: North America Leading the Market
North America was the largest region in the safety syringe market in 2023, while Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the safety syringe market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Access the complete report for an in-depth analysis of the global safety syringe market:
https://www.thebusinessresearchcompany.com/report/safety-syringe-global-market-report

Safety Syringe Global Market Report 2024 from TBRC covers the following information:
•Market size data for the forecast period: Historical and Future
•Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Safety Syringe Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on safety syringe market size, safety syringe market drivers and trends, safety syringe market major players, competitors' revenues, market positioning, and market growth across geographies. The safety syringe market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

Respiratory Monitoring Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/respiratory-monitoring-devices-global-market-report

Smart Pills Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/smart-pills-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next